|4Feb 19, 8:01 PM ET

Berger Mark Stanley 4

4 · Genprex, Inc. · Filed Feb 19, 2025

Insider Transaction Report

Form 4
Period: 2025-02-18
Berger Mark Stanley
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2025-02-18$0.41/sh585$24022,471 total
Footnotes (1)
  • [F1]Represents shares withheld on February 18, 2025 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") previously granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4